©The Author(s) 2025.
World J Diabetes. Dec 15, 2025; 16(12): 111963
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.111963
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.111963
Table 4 Mendelian randomization analysis of associations of plasma proteins with diabetic neuropathy in replicated stage (United Kingdom biobank pharma proteomics project vs genome-wide association studies catalog)
| Outcome | Exposure | Method | nSNP | β | SE | P value |
| GCST90129436 | HSPA1B | Inverse variance weighted | 3 | - | 0.61 | 0.320 |
| 0.60 | 0 | |||||
| 6 | ||||||
| GCST90129436 | SCGN | Wald ratio | 1 | 1.322 | 0.627 | 0.035 |
| GCST90129436 | MICB | Inverse variance weighted | 27 | -0.132 | 0.062 | 0.035 |
| GCST90129436 | WARS | Inverse variance weighted | 2 | -0.211 | 0.215 | 0.326 |
| GCST90129436 | BRD2 | (-) | - | - | - | - |
| GCST90129436 | CSNK2B | (-) | - | - | - | - |
| GCST90129436 | PSMB9 | (-) | - | - | - | - |
| GCST90129436 | BTN3A1 | (-) | - | - | - | - |
| GCST90129436 | NOTUM | (-) | - | - | - | - |
- Citation: Ding XF, Dang X, Lin S. Identification of novel therapeutic targets for diabetic neuropathy through integrated proteomics and transcriptomics approaches. World J Diabetes 2025; 16(12): 111963
- URL: https://www.wjgnet.com/1948-9358/full/v16/i12/111963.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i12.111963